Mutations in the amyloid ␤ precursor protein (APP) gene cosegregate with autosomal dominant Alzheimer disease (AD). Brain pathology of AD is characterized by amyloid deposition in senile plaques and by neurofibrillary tangles. Amyloid deposits in AD brains consist of amyloid ␤ (A␤), a 4-kDa proteolytic product of APP. In contrast, two other mutations in APP, the Flemish APP692 and Dutch APP693 mutations, are associated with autosomal dominant cerebral hemorrhages due to congophilic amyloid angiopathy (CAA) in the presence or absence of AD pathology, respectively. Both mutations are located within A␤ near the constitutive cleavage site. While a common effect of AD-linked mutations is to elevate A␤42 extracellular concentrations, not much is known about the effect of APP692 and APP693. Here we provide evidence that APP692 and APP693 have a different effect on A␤ secretion as determined by cDNA transfection experiments. While APP692 upregulates both A␤40 and A␤42 secretion, APP693 does not. These data corroborate with previous findings that increased A␤ secretion and particularly of A␤42, is specific for AD pathology.
INTRODUCTION
Missense mutations in the amyloid ␤ precursor protein (APP) gene on chromosome 21q21 have been shown to cosegregate with early-onset Alzheimer disease (AD). AD is a neurodegenerative disorder of the central nervous system characterized by memory and cognitive deficits leading to dementia and ultimately death. Brain pathology in AD patients shows typical brain lesions, i.e., extracellular senile plaques and intracellular neurofibrillary tangles. The senile plaques are found mainly in the cerebral cortex and hippocampus and consist of a large amyloid core surrounded by dystrophic neurites. The amyloid itself has been identified as amyloid ␤ (A␤), a 4-kDa peptide derived by proteolytic processing from APP. A␤ was also shown to be present in AD brains, although to a lesser extent, as amyloid aggregates in diffuse plaques without dystrophic neurites and in blood vessels as vascular amyloid. It is believed that A␤ deposition is the earliest morphological sign in AD, triggering a neuronal response characterized by the appearance of the dystrophic neurites and neurofibrillary tangles (Selkoe, 1994) .
APP is a glycosylated type I membrane protein with a single transmembrane domain appearing in different isoforms of which the one with 695 amino acids (APP695) is most abundant in brain (Kang et al., 1987) . In vitro and in vivo studies have shown that APP is processed through two different pathways of which the first involves cleavage of APP within the A␤ sequence by a protease refered to as ␣-secretase (Fig. 1) . The second proteolytic pathway involves cleavage by 1 To whom correspondence should be addressed. 281-286 (1998) Article No. NB980202
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